Ratings Summary for LUVOX
Overall Patient opinion of LUVOX: 3.2 (satisfied)
(based on 320 reviews ) (updated May 6, 2025)Ratings by Age Group for LUVOX
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Age Group | Number of Reviews | Average Rating |
|---|---|---|
| Pediatric (Under 18) | 23 | 2.5 |
| Age 18 to 24 | 58 | 3.4 |
| Age 25 to 34 | 107 | 3.4 |
| Age 35 to 44 | 59 | 3.2 |
| Age 45 to 54 | 43 | 2.9 |
| Age 55 to 64 | 19 | 3.1 |
| Age 65 to 74 | 1 | 3 |
| Age 75 and up |
Ratings by Sex for LUVOX
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Sex | Number of Reviews | Average Rating |
|---|---|---|
| Male | 128 | 3.390625 |
| Female | 185 | 3.09189189189189 |
| Not Specified | 6 | 3 |
Would you like to find reviews for LUVOX taken for a specific reason or resulting in a specific side effect?
Filter Results for LUVOX
FDA Drug Safety Information for LUVOX
Check here for Ask a Patient's Adverse Event Summary for LUVOX based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.
LUVOX (FLUVOXAMINE MALEATE): Fluvoxamine is used to treat obsessive-compulsive disorder (OCD). It helps decrease persistent/unwanted thoughts (obsessions) and urges to perform repeated tasks (compulsions such as hand-washing, counting, checking) that interfere with daily living. Fluvoxamine is known as a selective serotonin reuptake inhibitor (SSRI). This medication works by helping to restore the balance of a certain natural substance (serotonin) in the brain. FDA Approval Date: 1994-12-05 (Sources: U.S. Centers for Medicare Services, FDA)
